文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Janice Brunetti
发表
Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer
M. Atkins, J. Sosman, M. Ernstoff, 2007, Clinical Cancer Research.